← Back to Clinical Trials
Recruiting NCT07264439

NCT07264439 Evaluation of the Effectiveness of Virtual Reality Headsets With Hypnotic Scenarios for Hygiene Care in Patients With Alzheimer's Disease or Related Disorders With Behavioral Disturbances

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07264439
Status Recruiting
Phase
Sponsor Centre Hospitalier Universitaire, Amiens
Condition Effectiveness
Study Type INTERVENTIONAL
Enrollment 24 participants
Start Date 2025-09-03
Primary Completion 2027-04

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
VR headsetstandard cares

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 24 participants in total. It began in 2025-09-03 with a primary completion date of 2027-04.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

A device combining a virtual reality (VR) headset with hypnotic scenarios may represent an effective tool to reduce anxiety and opposition during hygiene care in patients with neurocognitive disorders presenting with behavioral and psychological symptoms. The primary objective of this project is to assess the feasibility and effectiveness of VR headsets with hypnotic scenarios compared with standard care in patients with ADRD presenting behavioral disturbances during hygiene care.

Eligibility Criteria

Inclusion Criteria: * Residents of the St-Victor center (CHU Amiens-Picardie), including nursing home units, reinforced care units, and long-term care units; * Patients diagnosed with ADRD presenting opposition or agitation during hygiene and toileting care; * Affiliation to a social security scheme, * Informed consent signed by the patient or legal representative. Exclusion Criteria: * Residents in terminal palliative care.

Contact & Investigator

Central Contact

Frédéric Bloch, MD

✉ Bloch.frederic@chu-amiens.fr

📞 33+3 22 08 80 51

Frequently Asked Questions

Who can join the NCT07264439 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Effectiveness. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07264439 currently recruiting?

Yes, NCT07264439 is actively recruiting participants. Contact the research team at Bloch.frederic@chu-amiens.fr for enrollment information.

Where is the NCT07264439 trial being conducted?

This trial is being conducted at Amiens, France.

Who is sponsoring the NCT07264439 clinical trial?

NCT07264439 is sponsored by Centre Hospitalier Universitaire, Amiens. The trial plans to enroll 24 participants.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology